Filing Flows

Filing Flows › Revolution Medicines (RVMD) › Who owns the stock

Who owns Revolution Medicines (RVMD) stock

672 funds reported Revolution Medicines (RVMD) shares in their latest 13F filings, worth $39.3B in all. The largest holder is BlackRock ($2.6B). Last quarter 424 funds added to their stakes and 199 cut them.

Largest holders of RVMD (13F)Largest holders of RVMD (13F)BlackRock$2.6BFMR LLC$2.3BBaker Bros. Advisors LP$2.1BDarwin Global Management$2.0BJupiter Topco LLC$2.0BVanguard Capital Management LLC$1.7BVanguard Portfolio Management LLC$1.6BNextech Invest$1.4BVanguard Group$1.3BParadigm Biocapital Advisors LP$1.2B

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock13,695,790$2.6Bincrease2026-06-30
FMR LLC12,200,422$2.3Bincrease2026-06-30
Baker Bros. Advisors LP11,443,357$2.1Bincrease2026-06-30
Darwin Global Management10,629,822$2.0Bincrease2026-06-30
Jupiter Topco LLC10,736,145$2.0Bbase2026-06-30
Vanguard Capital Management LLC9,088,661$1.7Bincrease2026-06-30
Vanguard Portfolio Management LLC8,294,855$1.6Bincrease2026-06-30
Nextech Invest7,601,087$1.4Bunchanged2026-06-30
Vanguard Group16,719,886$1.3Bincrease2025-12-31
Paradigm Biocapital Advisors LP6,361,323$1.2Bdecrease2026-06-30
UBS Group AG5,448,364$1.0Bincrease2026-06-30
Janus Henderson Group9,766,496$950Mdecrease2026-03-31
State Street4,897,051$917Mincrease2026-06-30
Capital World Investors4,008,244$751Mnew2026-06-30
Geode Capital Management, LLC3,942,676$737Mincrease2026-06-30

Revolution Medicines' latest quarter

Revolution Medicines, Q3 2026: revenue $198M, operating margin -188.9%, net loss $407M, operating cash flow −$416M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most RVMD stock?

By the latest 13F filings: BlackRock ($2.6B); FMR LLC ($2.3B); Baker Bros. Advisors LP ($2.1B); Darwin Global Management ($2.0B); Jupiter Topco LLC ($2.0B).

What is the short interest in RVMD?

12,934,780 shares were sold short at the 2026-10-15 settlement, 8.46% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.